Ion channels in T lymphocytes: An update on facts, mechanisms and therapeutic targeting in autoimmune diseases

Zoltan Varga, Peter Hajdu, G. Panyi

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

During the last quarter of a century a large body of evidence was gathered about the involvement of ion channels in T lymphocyte activation. A series of remarkable findings promoted T cell ion channels to become potential pharmaceutical targets in the therapy of autoimmune disorders. Numerous comprehensive reviews describe the types of ion channels found in the plasma membrane of T cells and their roles in signaling pathways leading to activation, the changes in the expression of these channels brought upon by differentiation to various T cell subsets, the formation and possible functions of signaling molecular clusters that include ion channels in the immunological synapse, the discovery and refinement of structurally different ion channel blockers and the successful in vivo application of such compounds to suppress hypersensitivity reactions and autoimmune processes. In this review we wish to provide a concise update on these topics from recent years, highlighting the most notable developments.

Original languageEnglish
Pages (from-to)19-25
Number of pages7
JournalImmunology Letters
Volume130
Issue number1-2
DOIs
Publication statusPublished - May 2010

Fingerprint

Ion Channels
Autoimmune Diseases
T-Lymphocytes
Immunological Synapses
Therapeutics
T-Lymphocyte Subsets
Lymphocyte Activation
Hypersensitivity
Cell Membrane
Pharmaceutical Preparations

Keywords

  • Immunological synapse
  • Immunosuppression
  • Ion channel
  • T cell activation

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Ion channels in T lymphocytes : An update on facts, mechanisms and therapeutic targeting in autoimmune diseases. / Varga, Zoltan; Hajdu, Peter; Panyi, G.

In: Immunology Letters, Vol. 130, No. 1-2, 05.2010, p. 19-25.

Research output: Contribution to journalArticle

@article{414fe979420b49f9944586945fdc2e44,
title = "Ion channels in T lymphocytes: An update on facts, mechanisms and therapeutic targeting in autoimmune diseases",
abstract = "During the last quarter of a century a large body of evidence was gathered about the involvement of ion channels in T lymphocyte activation. A series of remarkable findings promoted T cell ion channels to become potential pharmaceutical targets in the therapy of autoimmune disorders. Numerous comprehensive reviews describe the types of ion channels found in the plasma membrane of T cells and their roles in signaling pathways leading to activation, the changes in the expression of these channels brought upon by differentiation to various T cell subsets, the formation and possible functions of signaling molecular clusters that include ion channels in the immunological synapse, the discovery and refinement of structurally different ion channel blockers and the successful in vivo application of such compounds to suppress hypersensitivity reactions and autoimmune processes. In this review we wish to provide a concise update on these topics from recent years, highlighting the most notable developments.",
keywords = "Immunological synapse, Immunosuppression, Ion channel, T cell activation",
author = "Zoltan Varga and Peter Hajdu and G. Panyi",
year = "2010",
month = "5",
doi = "10.1016/j.imlet.2009.12.015",
language = "English",
volume = "130",
pages = "19--25",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Ion channels in T lymphocytes

T2 - An update on facts, mechanisms and therapeutic targeting in autoimmune diseases

AU - Varga, Zoltan

AU - Hajdu, Peter

AU - Panyi, G.

PY - 2010/5

Y1 - 2010/5

N2 - During the last quarter of a century a large body of evidence was gathered about the involvement of ion channels in T lymphocyte activation. A series of remarkable findings promoted T cell ion channels to become potential pharmaceutical targets in the therapy of autoimmune disorders. Numerous comprehensive reviews describe the types of ion channels found in the plasma membrane of T cells and their roles in signaling pathways leading to activation, the changes in the expression of these channels brought upon by differentiation to various T cell subsets, the formation and possible functions of signaling molecular clusters that include ion channels in the immunological synapse, the discovery and refinement of structurally different ion channel blockers and the successful in vivo application of such compounds to suppress hypersensitivity reactions and autoimmune processes. In this review we wish to provide a concise update on these topics from recent years, highlighting the most notable developments.

AB - During the last quarter of a century a large body of evidence was gathered about the involvement of ion channels in T lymphocyte activation. A series of remarkable findings promoted T cell ion channels to become potential pharmaceutical targets in the therapy of autoimmune disorders. Numerous comprehensive reviews describe the types of ion channels found in the plasma membrane of T cells and their roles in signaling pathways leading to activation, the changes in the expression of these channels brought upon by differentiation to various T cell subsets, the formation and possible functions of signaling molecular clusters that include ion channels in the immunological synapse, the discovery and refinement of structurally different ion channel blockers and the successful in vivo application of such compounds to suppress hypersensitivity reactions and autoimmune processes. In this review we wish to provide a concise update on these topics from recent years, highlighting the most notable developments.

KW - Immunological synapse

KW - Immunosuppression

KW - Ion channel

KW - T cell activation

UR - http://www.scopus.com/inward/record.url?scp=77950945397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950945397&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2009.12.015

DO - 10.1016/j.imlet.2009.12.015

M3 - Article

C2 - 20026117

AN - SCOPUS:77950945397

VL - 130

SP - 19

EP - 25

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 1-2

ER -